佐列龙酸和帕米德罗纳酸对功能的影响
Katherine Koss1, Melissa Kocek1, Tiffany King1
1Department of Pharmacy, Rush University Medical Center; Chicago, IL, USA.
概括
双类药物,如佐勒龙酸和帕米德酸,不会增加急性损伤 (AKI) 的风险,即使在患有先前存在问题的患者中也是如此. 长期的效应是罕见的,适当的水分和管理.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 关于双酸盐对功能影响的数据有限,特别是在基线功能障碍患者中.
- 双酸盐对于管理恶性瘤高血症至关重要.
研究的目的:
- 为了确定急性损伤 (AKI) 的发病率,在服用佐勒龙酸和帕米德罗纳酸后.
- 评估具有或没有先前存在的功能障碍的患者的AKI风险.
主要方法:
- 对接受单剂量佐列龙酸或帕米德罗纳酸的患者进行回顾性队列分析.
- 基线特征的比较和初级和二级结果的未经调整的分析.
- 统计分析使用皮尔森的千平方,费舍尔的精确测试,和曼-惠特尼U测试.
主要成果:
- 索尔德罗尼酸和帕米德罗纳酸 (17.1%与15.0%) 之间的AKI发病率没有显著差异.
- 在患有和没有基线功能障碍的患者 (25.0%与15.0%) 之间,AKI发病率没有差异.
- 没有观察到校正的,血清肌素,发烧或低酸血症发生率的差异.
结论:
- 双酸盐可以安全地用于患有或没有功能障碍的患者的恶性血症.
- 虽然AKI可以发生在输液后,但长期的影响在适当的患者水分和遵守药物管理准则的情况下是罕见的.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
62
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
144
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
144
Heart Failure Drugs: Diuretics
350
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
350
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K


